Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study
Open accessThe DOI matches its Crossref record; 84 of the 86 references it cites were found in a registry or an index; 6 of the 21 sources its claims cite were checked for support.
Abstract
Several health-promoting effects of kefir have been suggested, however, there is limited evidence for its potential effect on gut microbiota in metabolic syndrome This study aimed to investigate the effects of regular kefir consumption on gut microbiota composition, and their relation with the components of metabolic syndrome. In a parallel-group, randomized, controlled clinical trial setting, patients with metabolic syndrome were randomized to receive 180 mL/day kefir (n = 12) or unfermented milk (n = 10) for 12 weeks. Anthropometrical measurements, blood samples, blood pressure measurements, and fecal samples were taken at the beginning and end of the study. Fasting insulin, HOMA-IR, TNF-α, IFN-γ, and systolic and diastolic blood pressure showed a significant decrease by the intervention of kefir (p ≤ 0.05, for each). However, no significant difference was obtained between the kefir and unfermented milk groups (p > 0.05 for each). Gut microbiota analysis showed that regular kefir consumption resulted in a significant increase only in the relative abundance of Actinobacteria (p = 0.023). No significant change in the relative abundance of Bacteroidetes, Proteobacteria or Verrucomicrobia by kefir consumption was obtained. Furthermore, the changes in the relative abundance of sub-phylum bacterial populations did not differ significantly between the groups (p > 0.05, for each). Kefir supplementation had favorable effects on some of the metabolic syndrome parameters, however, further investigation is needed to understand its effect on gut microbiota composition.
Overview
CoChat Summary
## TL;DR
This randomized controlled study tested 12 weeks of kefir (180 mL/day) versus unfermented milk in adults with metabolic syndrome and found some within-group improvements in insulin resistance, inflammatory markers, blood pressure, and gut microbiota, but no significant differences between groups for these outcomes. Kefir significantly increased only the relative abundance of Actinobacteria (p = 0.023), while overall diversity measures and most microbiota changes were not significant.
## Key findings
- A total of 22 participants completed the trial after randomization of 40 eligible participants; 12 received kefir and 10 received unfermented milk.
- After 12 weeks, kefir was associated with significant within-group decreases in fasting insulin and HOMA-IR (p = 0.050), TNF-α (p = 0.015), IFN-γ (p = 0.013), systolic BP (p = 0.041), and diastolic BP (p = 0.019), but these improvements were not significant versus the milk group.
- Gut microbiota analysis showed a significant increase only in Actinobacteria with kefir (p = 0.023); no significant change was observed for Bacteroidetes, Proteobacteria, or Verrucomicrobia.
- No significant differences were found between groups in alpha/beta diversity metrics, OTU counts, Firmicutes/Bacteroidetes ratio, or changes in sub-phylum taxa; no side effects were reported.
## Methods
- Parallel-group, randomized, controlled clinical trial in adults aged 18–65 years with metabolic syndrome, recruited from Ege University outpatient clinic; trial ran from March 2015 to July 2017 and was registered as NCT03966846.
- Participants were randomized to kefir (180 mL/day, n = 12) or unfermented milk (180 mL/day, n = 10) for 12 weeks; diets and physical activity were intended to remain habitual.
- Outcomes included 24-h dietary recalls, anthropometry, fasting blood biomarkers, blood pressure, fecal 16S rRNA sequencing of the V3-V4 region, and statistical comparisons/correlations using tests including Kruskal–Wallis, Mann–Whitney U, Spearman, and PERMANOVA.
## Limitations
- The paper states that it examined only microbiota composition, not microbiota functionality; it says that metabolite-based markers could have improved interpretation and calls this the main limitation.
- The paper states that the small number of participants in each arm is another limitation.
- Evident from the text: despite randomization, the final sample was small (22 completers), which limits precision and makes between-group comparisons underpowered.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Principal coordinate analysis (PCoA) plot of the unweighted (A) and weighted (B) UniFrac distance matrices in the study groups. The plots were generated using EMPeror [36]. Axis titles indicate the percentage variations. The colors indicate sampling time (red: week 0, blue: week 12).](https://figures.cochat.ai/paper-figures/8c30915e06de4ec8baf794ccba189570/effects-of-regular-kefir-consumption-on-gut-microbiota-in-patients-with-figure-5.jpg)
Verification
Claims the paper makes
5 Valid · 0 Not valid · 5 Not checked · 75 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Primary, the low-grade chronic inflammation state in MetS has been explained by the metabolic endotoxemia that was a result of gut dysbiosis [6,7].”
§ Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study > 1. Introduction
What the sources say
- Supportedcites [6] Burcelin, 2009, The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?, Front Biosci source
Section 2.4 (p. n/a) states that a fat-enriched diet dramatically changes the gut microflora and that 'the molecular mechanisms linked to the change in microflora was related to the release into the blood of an extract from Gram negative bacteria: lipopolysaccharides (LPS)', which 'can trigger a metabolic inflammatory state' leading to insulin resistance and obesity. Section 4.4 makes the same causal chain explicit (intestinal microflora regulates the inflammatory tone; endotoxemia 2-3 fold correlated with inflammation; linked to a 100-fold reduction of Bifidobacteria), and Section 5.1 extends it to metabolic syndrome in humans ('the origin of the endotoxemia is related to the intestinal microflora ... controlling the intestinal flora and enteric LPS permeability would be a key target for the control of the onset of inflammation-induced metabolic diseases'; 'A growing body of evidence supports the influence of the endotoxin pathway in metabolic syndrome'). The citing sentence's chain — gut dysbiosis → metabolic endotoxemia → low-grade inflammation in MetS — is thus the paper's own account, though the underlying experimental data are the author's mouse/human studies (refs 20, 22, 54) rather than a MetS trial. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [7] Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although the effects of probiotic and prebiotic supplementation on metabolic health have been examined in previous studies, the results are inconsistent due to the choice of probiotic strain, formulation of the probiotic, outcome of interest, and duration of the intervention [12,13,14].”
§ Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study > 1. Introduction
What the sources say
- Partly supportedcites [12] Festi, 2014, Gut microbiota and metabolic syndrome, World J. Gastroenterol. sourceExperimental — accuracy not yet measured
Our copy does support the 'inconsistent results' half of the claim: the Prebiotics section (p. 10) reports that a meta-analysis found significant reductions in post-prandial glucose and insulin while 'data regarding effects on body weight, total energy intake, satiety, GLP-1 and peptide YY production and inflammatory pattern seem to be controversial', and the Probiotics section (p. 9) states that despite promising results the evidence for probiotics in obesity 'are still weak' and their therapeutic use 'has not yet been recommended'; the CONCLUSION (p. 10) repeats that solid clinical evidence has not emerged. However, the paper nowhere attributes this inconsistency to the specific reasons the citing sentence gives — choice of probiotic strain, formulation of the probiotic, outcome of interest, and duration of intervention; its tables merely list heterogeneous strains, doses and durations without offering them as the explanation. That explanatory part of the claim is not in our copy. (LLM, conf=0.72)
- Partly supportedcites [13] Anhe, 2015, Probiotics as Complementary Treatment for Metabolic Disorders, Diabetes Metab. J. sourceExperimental — accuracy not yet measured
The Conclusions report inconclusive probiotic results and attribute difficulty comparing studies to differences in protocols, including treatment duration. The paper also discusses strain-specific effects, product formulations, and differing metabolic outcomes. Its discussion of prebiotics does not establish that prebiotic supplementation has similarly inconsistent results for these reasons. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [14] Cani, 2015, Novel opportunities for next–generation probiotics targeting metabolic syndrome, Curr. Opin. Biotechnol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Most of the animal and human studies have reported that obesity and insulin resistance are associated with an altered ratio of Firmicutes and Bacteroidetes [8,9].”
§ Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study > 1. Introduction
What the sources say
- Partly supportedcites [8] Ley, 2005, Obesity alters gut microbial ecology, Proc. Natl. Acad. Sci. USA sourceExperimental — accuracy not yet measured
The Results and Discussion report that obese ob/ob mice had fewer Bacteroidetes and more Firmicutes than lean mice. This supports the obesity–altered-ratio association in one animal study, but the paper does not establish what most animal and human studies report or link the ratio to insulin resistance; it says the obesity finding deserves exploration in humans. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [9] Backhed, 2005, Host–bacterial mutualism in the human intestine, Science source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, the initial metabolic profile of the participants was suggested an essential factor for the efficacy of probiotic interventions.”
§ Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study > 4. Discussion
What the sources say
- Partly supportedcites [43] Fuentes, 2013, Cholesterol–lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults, Br. J. Nutr. sourceExperimental — accuracy not yet measured
The Discussion passage ('This finding may suggest that patients with higher levels of TC may benefit from higher reductions... the biofunctionality of L. plantarum could be proportional to the cardiovascular risk of the patient') together with the 'Stratification of the patients' results (HIV 17·4/17·6 % v. LIV 9·4/11·5 % TC/LDL-C reductions) and the Abstract do attribute a role to participants' baseline lipid status in the size of the probiotic effect. However, the source frames this only as a suggestion ('may suggest', 'could be proportional') and restricts it to baseline TC in hypercholesterolaemic adults taking L. plantarum CECT 7527/7528/7529; the citing sentence states it as an 'essential factor' for 'probiotic interventions' in general, which overstates and widens what this paper supports. (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [44] Nikbakht, 2018, Effect of probiotics and synbiotics on blood glucose: a systematic review and meta–analysis of controlled trials, Eur. J. Nutr. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In particular, insulin and HOMA–IR levels were significantly decreased, and also pro–inflammatory cytokines (TNF–α and IFN–γ) and blood pressure were ameliorated by kefir consumption.”
§ Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study > 4. Discussion
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
41 more claims
Create a free account to see all 85 claims and to verify the 3 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 14
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Kefir consumption does not seem to result in negative effects (18) for adult humans (19) or animals (20).”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This intestinal modulation interferes with metabolic parameters, characteristic of metabolic syndrome, showing improvement in fasting insulin and insulin resistance index (HOMA-IR), and a decrease in pro-inflammatory cytokines, such as TNF-α and interferon-gama (IFN-γ), and in systolic and diastolic pressure.”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“body weight gain and BMI were positively correlated with the relative abundance of Firmicutes and Proteobacteria and negatively correlated with the relative abundance of Clostridia.”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“In humans, modulation of intestinal microbiota also occurs after the consumption of kefir, as discussed by Bellikci-Koyu et al. (19) who investigated individuals with metabolic syndrome that were supplemented with kefir for 12 weeks (Table 1). After the intervention, there was a significant increase in Actinobacteria, as well as changes in the genera of the phyla Bacteriodetes and Firmicutes, in”
From Kefir and Intestinal Microbiota Modulation: Implications in Human Health (2021) · cites this paper as [19]
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
DADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698 · cited 1×
“For this purpose, raw data were imported into QIIME2 [31], filtered and controlled for quality and chimeric sequences using DADA2, q2-demux, and dblur scripts [32,33].”
MethodReproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0209-9 · Cited by 23,742
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“showed the linked between gut microbiota and obesity, there has been growing evidence that suggests a causal relationship between gut microbiota and the components of MetS [5].”
BackgroundKlindworth, A., Pruesse, E., Schweer, T., Peplies, J., Quast, C., Horn, M., & Glöckner, F. O. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks808 · Cited by 8,850 · cited 1×
“The 16S rRNA sequences were amplified using previously-described primers targeting the V3-V4 region, frequently used to study bacterial diversity [27], with Illumina adapter overhang sequences added, as directed by the manufacturer.”
MethodHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 1×
“Our results supported the previous reports, which revealed increased Firmicutes and decreased the abundance of Bacteroidetes are associated with obesity [64].”
ResultA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1×
“revealed a higher proportion of Actinobacteria in obese individuals compared to lean individuals [65].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Research works printed but not linked: 1
- Koyu, 2018, A functional food: Kefir, J. Nutr. Diet., 46, 166
Cited by
Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration
Leeming, E. R., Johnson, A. J., Spector, T. D., & Le Roy, C. I. (2019) · Nutrients · doi:10.3390/nu11122862 · Cited by 817
“Bellikci-koyu [71] 2019 Humans 22 Randomised parallel, controlled trial 24-h food recall × 2 (week 0, week 12) Two treatment groups: (1) 180 mL/day kefir (12); (2) unfermented milk (10) control 12 weeks 2× samples: baseline, end of intervention No Kefir was associated with a significant increase in the relative abunda…”
MethodKefir and Its Biological Activities
Azizi, N. F., Kumar, M. R., Yeap, S. K., Abdullah, J. O., Khalid, M., Omar, A. R., Osman, M. A., Mortadza, S. A. S., & Alitheen, N. B. (2021) · Foods · doi:10.3390/foods10061210 · Cited by 256
“A randomized trial in twelve subjects with metabolic syndrome whose diets were supplemented with 180 mL/day kefir showed the modulation of intestinal microbiota, with a significant rise in Actinobacteria, as well as variations in the genera of the phyla Bacteriodetes and Firmicutes [181].”
BackgroundThe Development and Evaluation of a Literature-Based Dietary Index for Gut Microbiota
Kase, B. E., Liese, A. D., Zhang, J., Murphy, E. A., Zhao, L., & Steck, S. E. (2024) · Nutrients · doi:10.3390/nu16071045 · Cited by 221
“Kefir and fermented dairy intake were associated with beneficial changes in gut microbiota, mainly an increase in actinobacteria [30].”
BackgroundEating Fermented: Health Benefits of LAB-Fermented Foods
Castellone, V., Bancalari, E., Rubert, J., Gatti, M., Neviani, E., & Bottari, B. (2021) · Foods · doi:10.3390/foods10112639 · Cited by 178
Guzel-Seydim, Z. B., Gökırmaklı, Ç., & Greene, A. K. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.04.041 · Cited by 172
Fermented foods: An update on evidence-based health benefits and future perspectives
Diez-Ozaeta, I., & Astiazaran, O. J. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111133 · Cited by 162
Fermented foods, their microbiome and its potential in boosting human health
Valentino, V., Magliulo, R., Farsi, D. N., Cotter, P. D., O’Sullivan, Ó., Ercolini, D., & Filippis, F. D. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.14428 · Cited by 183
Functional Foods in Modern Nutrition Science: Mechanisms, Evidence, and Public Health Implications
Fekete, M., Lehoczki, A., Kryczyk‐Poprawa, A., Zábó, V., Varga, J. T., Bálint, M., Fazekas‐Pongor, V., Csípő, T., Rząsa-Duran, E., & Varga, P. (2025) · Nutrients · doi:10.3390/nu17132153 · Cited by 228
“Bellikci-Koyu et al. [137] also reported significant decreases in fasting insulin, HOMA-IR, and inflammatory markers, though no statistically significant differences were found between the kefir and control groups.”
Balasubramanian, R., Schneider, E., Gunnigle, E., Cotter, P. D., & Cryan, J. F. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105562 · Cited by 152
Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites
Croci, S., D'Apolito, L. I., Gasperi, V., Catani, M. V., & Savini, I. (2021) · Nutrients · doi:10.3390/nu13051389 · Cited by 121
Kefir and Intestinal Microbiota Modulation: Implications in Human Health
Peluzio, M. D. C. G., Dias, M. D. M. E., Martinez, J. A., & Milagro, F. I. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.638740 · Cited by 92
Tu, M.-Y., Han, K.-Y., Chang, G. R.-L., Lai, G.-D., Chang, K.-Y., Chen, C.-F., Lai, J.-C., Lai, C.-Y., Chen, H.-L., & Chen, C.-M. (2020) · Nutrients · doi:10.3390/nu12113432 · Cited by 88
“The consumption of kefir or kefir-like dairy products may have a great impact on the structure of the gut microbiota [17,18], but the link between gut microbiota changes and bone health is limited.”
BackgroundGao, Y., Liu, Y., Ma, T., Liang, Q., Sun, J., Wu, X., Song, Y., Nie, H., HUANG, J. C., & Mu, G. (2025) · Foods · doi:10.3390/foods14111946 · Cited by 126
“In adults with metabolic syndrome, 12 weeks of daily kefir (180 mL/day) raised the relative abundance of Actinobacteria ( p = 0.023), and improved favorable effects on some metabolic syndrome parameters [48].”
InfluentialRoselli, M., Natella, F., Zinno, P., Guantario, B., Canali, R., Schifano, E., Angelis, M. D., Nikoloudaki, O., Gobbetti, M., Perozzi, G., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.689084 · Cited by 90
“Food Matrices and Microbial Composition The majority of foods were dairies, in particular yogurt (20, 21) and kefir (22, 23), but also cheeses, such as Parmigiano Reggiano (Parmesan) (24) and Camembert (28, 29).”
BackgroundA Review of the Relationship between Gut Microbiome and Obesity
Zsálig, D., Berta, A., Tóth, V., Szabó, Z., Klara, S. M., Figler, M., Pusztafalvi, H., & Polyák, É. (2023) · Applied Sciences · doi:10.3390/app13010610 · Cited by 88
The Microbiota–Gut–Brain Axis in Metabolic Syndrome and Sleep Disorders: A Systematic Review
dos Santos, A., & Galié, S. (2024) · Nutrients · doi:10.3390/nu16030390 · Cited by 92
“…benefit of daily consumption of fermented foods like kefir was also tested in subjects with MetS, and no difference in metabolic parameters, including insulin, glucose, and cholesterol levels, was observed [84], nor did the gut microbiota composition experience great shifts in its composition.”
BackgroundFeng, J. B., Gao, M., Zhao, C., Yang, J., Gao, H., Lü, X., Ju, R., Zhang, X., & Zhang, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.823288 · Cited by 84
Salari, A., Ghodrat, S., Gheflati, A., Jarahi, L., Hashemi, M. B., & Afshari, A. (2021) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2021.101443 · Cited by 79
Attaye, I., Warmbrunn, M. V., Boot, A. N. A. F., van der Wolk, S. C., Hutten, B. A., Daams, J. G., Herrema, H., & Nieuwdorp, M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.02.011 · Cited by 60
Koyu, E. B., Sarer-Yurekli, B. P., Karagözlü, C., Köse, F. A., Özgen, G., & Büyüktuncer, Z. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.02.006 · Cited by 59
Self-citationDeveci, G., Çelik, E., Ağagündüz, D., Bartkienė, E., Rocha, J. M., & Özoğul, F. (2023) · Fermentation · doi:10.3390/fermentation9110923 · Cited by 59
Kiesswetter, E., Stadelmaier, J., Πετροπούλου, Μ., Morze, J., Grummich, K., Roux, I., Lay, R., Himmelsbach, L., Kussmann, M., Roeger, C., et al. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.03.004 · Cited by 50
“certainty) (Supplemental Figures 3H and Supplemental Table 25) [43,44,46,47,52,53,57,59,60].”
BackgroundNutritional Characteristics, Health Impact, and Applications of Kefir
Apalowo, O. E., Adegoye, G. A., Mbogori, T. N., Kandiah, J., & Obuotor, T. M. (2024) · Foods · doi:10.3390/foods13071026 · Cited by 62
Calatayud, M., Börner, R. A., Ghyselinck, J., Verstrepen, L., Medts, J. D., den Abbeele, P. V., Boulangé, C. L., Priour, S., Marzorati, M., & Damak, S. (2021) · Nutrients · doi:10.3390/nu13113897 · Cited by 55
“Significant increases in the relative abundance of Actinobacteria have been reported in a parallel-group, randomized, controlled clinical trial setting with patients with metabolic syndrome receiving milk kefir compared to unfermented milk during 12 weeks [60], a trait also observed in this study.”
BackgroundKefir improves blood parameters and reduces cardiovascular risks in patients with metabolic syndrome
Ghizi, A. C. D. S., Silva‐Cutini, M. A., Moraes, F. D. S. A., da Silva, C. L., Endringer, D. C., Scherer, R., Lenz, D., de Lima, E. M., Brasil, G. A., Parreiras, J. F. M., et al. (2021) · PharmaNutrition · doi:10.1016/j.phanu.2021.100266 · Cited by 60
Akar, F., Şumlu, E., Alçığır, M. E., Bostancı, A., & Sadı, G. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110287 · Cited by 45
Ecklu-Mensah, G., Miller, R., Maseng, M. G., Hawes, V., Hinz, D., Kim, C., & Gilbert, J. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-80281-w · Cited by 58
“…human dietary intervention studies have indicated associations between the consumption of diets rich in fermented foods and reduced disease risk, enhanced longevity, and improved quality of life (Bellikci-Koyu et al., 2019; González et al., 2019; Hill et al., 2023; Marco et al., 2017, 2021).”
Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging
Barone, M., D’Amico, F., Rampelli, S., Brigidi, P., & Turroni, S. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111711 · Cited by 34
Kefir in the Prevention and Treatment of Obesity and Metabolic Disorders
Bourrie, B. C. T., Richard, C., & Willing, B. P. (2020) · Current Nutrition Reports · doi:10.1007/s13668-020-00315-3 · Cited by 41
Metagenomic features of Tibetan kefir grains and its metabolomics analysis during fermentation
Cui, Y., Wang, X., Yue, Y., Du, G., Chen, H., Ning, M., Yuan, Y., & Yue, T. (2023) · LWT · doi:10.1016/j.lwt.2023.114502 · Cited by 36
Chen, T., Wang, J., Liu, Z., & Gao, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1282699 · Cited by 37
Saadati, S., Naseri, K., Asbaghi, O., Yousefi, M., Golalipour, E., & de Courten, B. V. (2023) · Obesity Reviews · doi:10.1111/obr.13667 · Cited by 40
Mederle, A. L., Dima, M. A., Stoicescu, E. R., Căpăstraru, B. F., Levai, C. M., Hațegan, O. A., & Maghiari, A. L. (2024) · Life · doi:10.3390/life14111485 · Cited by 42
Effect of Consumption of Animal Products on the Gut Microbiome Composition and Gut Health
Lee, C., Lee, J., Eor, J. Y., Kwak, M., Huh, C., & Kim, Y. (2023) · Food Science of Animal Resources · doi:10.5851/kosfa.2023.e44 · Cited by 35
Milk kefir alters fecal microbiota impacting gut and brain health in mice
Pereira, M. D. F. A., de Ávila, L. G. M., Alpino, G. D. C. Á., Cruz, B. C. D. S., Almeida, L. F., Simões, J. M., Bernardes, A. L., Campos, I. X., Ribon, A. D. O. B., Mendes, T. A. D. O., et al. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12630-0 · Cited by 35
Bourrie, B. C. T., Forgie, A. J., Makarowski, A., Cotter, P. D., Richard, C., & Willing, B. P. (2023) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2022-0463 · Cited by 29
Bae, D., Kim, D., Chon, J., Song, K., & Seo, K. (2020) · Poultry Science · doi:10.1016/j.psj.2020.07.032 · Cited by 26
Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?
Horvath, A., Žukauskaitė, K., Hazia, O., Balázs, I., & Stadlbauer, V. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.436 · Cited by 33
“37 The benefits of fermented dairy products on changes in insulin resistance were investigated in a randomized, parallel and controlled clinical study where MetS patients with fatty liver disease consumed 220 g per day of yogurt or unfermented milk (in the control group).”
BackgroundHealth Benefits of Functional Foods
Jurek, J. M. (2022) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1598 · Cited by 27
Commercial kefir products assessed for label accuracy of microbial composition and density
Metras, B. N., Holle, M. J., Parker, V. J., Miller, M. J., & Swanson, K. S. (2021) · JDS Communications · doi:10.3168/jdsc.2020-0056 · Cited by 28
Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime
Medina-Rodriguez, E. M., Martínez-Raga, J., & Sanz, Y. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001202 · Cited by 34
Kairey, L., Leech, B., El‐Assaad, F., Bugarc̀ić, A., Dawson, D. E., & Lauche, R. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac054 · Cited by 35
Chelliah, R., Kim, N. H., Park, S., Park, Y.-S., Yeon, S., Barathikannan, K., Vijayalakshmi, S., & Oh, D. (2024) · Fermentation · doi:10.3390/fermentation10040195 · Cited by 24
Elechi, J. O. G., Sirianni, R., Conforti, F. L., Cione, E., & PELLEGRINO, M. A. (2023) · Foods · doi:10.3390/foods12122286 · Cited by 32
Culpepper, T. (2022) · Cureus · doi:10.7759/cureus.27768 · Cited by 28
“In another study by the same group, both kefir and the placebo lowered serum concentrations of both insulin and the same cytokines; thus, these decreases cannot be attributed to kefir administration [67].”
BackgroundMcGovern, C. J., González‐Orozco, B. D., & Jiménez‐Flores, R. (2024) · Journal of Dairy Science · doi:10.3168/jds.2023-24364 · Cited by 31
Hric, I., Ugrayová, S., Penesová, A., Rádiková, Ž., Kubáňová, L., Šardzíková, S., Baranovičová, E., Kľúčár, Ľ., Beke, G., Grendár, M., et al. (2021) · Nutrients · doi:10.3390/nu13061753 · Cited by 28
“In another study, Lactobacillales were increased after kefir administration in patients with metabolic syndrome [59].”
BackgroundTravičić, V., Šovljanski, O., Tomić, A., Perović, M. N., Milošević, M. M., Ćetković, N. B., & Antov, M. G. (2023) · Foods · doi:10.3390/foods12224163 · Cited by 24
Effects of fermented dairy products on inflammatory biomarkers: A meta-analysis
Zhang, X., Luo, Q., Guan, X.-X., Tang, Y., Chen, X., Deng, J., & Fan, J. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.12.014 · Cited by 32
Cabral, L. Q. T., Ximenez, J. A., Moreno, K. G. T., & Fernandes, R. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.028 · Cited by 26
Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease
López‐Yerena, A., Villaplana, V. D. S., Badimón, L., Vilahur, G., & Padró, T. (2024) · Nutrients · doi:10.3390/nu17010052 · Cited by 24
Impact of Fermented Milk On Gut Microbiota And Human Health: A Comprehensive Review
EL‐SALAM, M. H. A., El‐Shibiny, S., Assem, F. M., El-Sayyad, G. S., Hasanien, Y. A., Elfadil, D., & Soliman, T. N. (2025) · Current Microbiology · doi:10.1007/s00284-025-04061-z · Cited by 21
“In a controlled clinical experiment with parallel groups, patients with metabolic syndrome were randomly assigned to consume 180 mL/day of kefir ( n = 12) or unfermented milk ( n = 10) for 12 weeks [79].”
Dairy products and constituents: a review of their effects on obesity and related metabolic diseases
Li, A., Han, X., Liu, L., Zhang, G., Du, P., Zhang, C., Li, C., & Chen, B. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2257782 · Cited by 20
“Bellikci-Koyu et al. (2019) first reported the effect of kefir on the composition of the intestinal flora in patients with MetS, with a significant increase in the gut Actinomycetes phylum in subjects supplemented with kefir compared to milk over 12 wk.”
Ibacache‐Quiroga, C., González-Pizarro, K., Charifeh, M., Canales, C., Díaz, R., Schmachtenberg, O., & Dinamarca, M. A. (2022) · Foods · doi:10.3390/foods11070900 · Cited by 21
Metras, B. N., Holle, M. J., Parker, V. J., Miller, M. J., & Swanson, K. S. (2020) · Journal of Animal Science · doi:10.1093/jas/skaa301 · Cited by 19
Current Research in Fermented Foods: Bridging Tradition and Science
Sampsell, K., Marcolla, C. S., Tapping, S., Fan, Y., Sánchez-Lafuente, C. L., Willing, B. P., Reimer, R. A., & Burton, J. P. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100554 · Cited by 31
“However, this reduction was not significantly different from the control group, who consumed 180 mL of milk per day, which may partly reflect the limited sample size ( n = 12 intervention, n = 10 control) [40].”
Choi, Y., Keum, G. B., Kang, J., Doo, H., Kwak, J., Kim, H., Chae, Y., Lee, S., Yang, H., Kim, S., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1587831 · Cited by 23
Kefir as a therapeutic agent in clinical research: a scoping review
Bessa, M. K., Bessa, G. R., & Bonamigo, R. R. (2023) · Nutrition Research Reviews · doi:10.1017/s0954422423000070 · Cited by 17
Catanzaro, R., Sciuto, M., He, F., Singh, B., & Marotta, F. (2020) · Acta Clinica Belgica · doi:10.1080/17843286.2020.1783907 · Cited by 13
“This condition is associated with an increased risk of Type 2 Diabetes Mellitus (T2DM), cardiovascular disease, and mortality for stroke or myocardial infarction [1,2].”
BackgroundMicrobial Communities in Home-Made and Commercial Kefir and Their Hypoglycemic Properties
Yılmaz, B., Elibol, E., Shangpliang, H. N. J., Özoğul, F., & Tamang, J. P. (2022) · Fermentation · doi:10.3390/fermentation8110590 · Cited by 18
“Similarly, a study on the effects of regular kefir consumption on gut microbiota composition, and their relation to the components of metabolic syndrome, was conducted [56].”
BackgroundAlves, E., Gregório, J., Rijo, P. M., Rosado, C., & Rodrigues, L. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192113791 · Cited by 15
“However, studies assessing the effect of kefir on the gut of individuals with pathologies associated with low-grade inflammation support kefir’s ability to positively impact both the gut and inflammation [14,18,49].”
BackgroundFoods of the Mediterranean diet: Lacto-fermented food, the food pyramid and food combinations
Medori, M. C., Naureen, Z., Bonetti, G., Aquilanti, B., Velluti, V., Matera, G., Iaconelli, A., & Bertelli, M. (2022) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2022.63.2s3.2744 · Cited by 37
“This could be due to the fact that kefir LAB colonize the gut epithelium, thereby exerting an influence on overall gut microbiota by niche exclusion and lactic acid production, which reduces the pH by creating an acidic environment that suppress the growth of bacteroides and induces the expression of genes encoding be…”
BackgroundFermented food: Should patients with cardiometabolic diseases go back to an early neolithic diet?
Mafra, D., Borges, N. A., Alvarenga, L., Ribeiro, M., Fonseca, L., Leal, V. O., Shiels, P. G., & Stenvinkel, P. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2077300 · Cited by 13
Yılmaz, İ., & ARSLAN, B. (2022) · Revista de Nutrição · doi:10.1590/1678-9865202235e210098 · Cited by 22
Invited review: Effect of antihypertensive fermented milks on gut microbiota
Beltrán‐Barrientos, L. M., Garcia, H. S., Hernández‐Mendoza, A., González-Córdova, A. F., & Vallejo‐Córdoba, B. (2021) · Journal of Dairy Science · doi:10.3168/jds.2020-19466 · Cited by 15
“tihypertensive effect of fermented milks and induced eubiosis (Bellikci-Koyu et al., 2019; de Almeida Silva et al., 2020).”
BackgroundDietary legumes and gut microbiome: a comprehensive review
Özdemir, A., & Büyüktuncer, Z. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2434725 · Cited by 17
“While studies on fermented dairy products (Bellikci-Koyu et al. 2019, Volokh et al. 2019), fruits/vegetables (Klinder et al. 2016, Fan et al. 2021) and whole grains (Costabile et al. 2008, Wu, Inui, and Chen 2020) had significant results, the relation between different legume types and gut…”
Self-citationKaul, R., Paul, P., Harfouche, M., Ayyan, M., Laws, S., & Châari, A. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103118 · Cited by 16
Adnan, M. L., & Dewi, M. D. (2020) · International Journal of Medical Students · doi:10.5195/ijms.2020.486 · Cited by 15
Mohammadi, F., Razmjooei, N., Mohsenpour, M. A., Nejati, M. A., Eftekhari, M. H., & Hejazi, N. (2025) · BMC Nutrition · doi:10.1186/s40795-024-00989-w · Cited by 14
Protective effects of kefir in the angiotensin II-dependent hypertension
Monteiro, B. L., Dias, A. T., Wanderkoke, S. D. C., Yokota, R., Casarini, D. E., Leal, M. A. S., Nogueira, B. V., Meyrelles, S. S., Campos‐Toimil, M., Campagnaro, B. P., et al. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104260 · Cited by 13
The Effects of Kefir on the Human Oral and Gut Microbiome
Black, E. G., Bugarc̀ić, A., Lauche, R., El-Omar, E. M., & El‐Assaad, F. (2025) · Nutrients · doi:10.3390/nu17243861 · Cited by 10
“In comparison, Bellikci-Koyu et al. [73] observed a significant increase in the relative abundance of Actinobacteria in individuals with metabolic syndrome.”
InfluentialUnlocking Innovations: Exploring the Role of Kefir in Product Development
Manjunatha, V., Bhattacharjee, D., & Flores, C. (2024) · Current Food Science and Technology Reports · doi:10.1007/s43555-024-00032-w · Cited by 13
Kefir alters craniomandibular bone development in rats fed excess dose of high fructose corn syrup
Ekici, Ö., Aslan, E., Güzel, H., Korkmaz, Ö. A., Sadı, G., Gurol, A. M., Boyacı, M. G., & Pektaş, M. B. (2021) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-021-01273-8 · Cited by 10
“Similarly, in the clinical trial, kefir 180 (ml/day) increased Actinobacteria and suppressed inflammation in patients with metabolic syndrome [40].”
BackgroundBhattacharya, S., Bhadra, R., Schols, A. M. W. J., & Sambashivaiah, S. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000688 · Cited by 10
“However, the direct impact of the changes in gut microbiome on muscle health was not examined [19,20].”
BackgroundNutrition, Microbiota and Noncommunicable Diseases
Plaza‐Díaz, J. (2020) · Nutrients · doi:10.3390/nu12071971 · Cited by 9
“[6] investigated the effects of regular kefir consumption on gut microbiota composition, and their relation with the components of metabolic syndrome in a parallel-group, randomized, controlled clinical trial for 12 weeks.”
BackgroundMethodSammallahti, H., Rezasoltani, S., Pekkala, S., Kokkola, A., Aghdaei, H. A., Looha, M. A., Ghanbari, R., Zamani, F., Sadeghi, A., Sarhadi, V. K., et al. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00698-0 · Cited by 10
“Actinobacteriota have been positively associated with the intake of resistant starch [117], which is found in foods such as legumes and cooked and cooled rice [118], as well as the consumption of fermented dairy products [119].”
Côco, L. Z., Aires, R., Carvalho, G. R., Belisário, E. D. S., Yap, M. K. K., Amorim, F. G., Conde, J., Nogueira, B. V., Vasquez, E. C., Pereira, T. D. M. C., et al. (2023) · Cells · doi:10.3390/cells12242799 · Cited by 11
The effect of kefir-spirulina on glycemic status and antioxidant activity in hyperglycemia rats
Laela, N., Legowo, A. M., & Fulyani, F. (2021) · Potravinarstvo Slovak Journal of Food Sciences · doi:10.5219/1445 · Cited by 12
“Therefore, kefir can give protection against free radicals and thus increase SOD activity (Niccolai et al., 2019; Bellikci-Koyu et al., 2019; Zhang, Wu and Fei, 2016).”
BackgroundFermented dairy product consumption and blood lipid levels in healthy adults: a systematic review
Yılmaz, B., Alvanoudi, P., Kalogeropoulou, A. G., Santa, D., Tüccar, T. B., Nikolaou, A., Moreno‐Indias, I., Ruiz‐Limón, P., Gutiérrez‐Repiso, C., Hillesheim, E., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1651134 · Cited by 18
Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota
Tieu, V., Tibi, S., & Ling, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1167827 · Cited by 9
“, Creactive protein) and erythrocyte sedimentation rate (Bellikci-Koyu et al., 2019; Wastyk et al., 2021; Zhang, X et al., 2021).”
BackgroundLawrence, K., Fibert, P., Toribio-Mateas, M. A., Gregory, A. M., Hobbs, J., Quadt, F., Wright, S., Cotter, P. D., Patel, S. H., & Myrissa, K. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07568-8 · Cited by 10
“It has been demonstrated that the consumption of kefir can positively alter the composition of the gut microbiome, in both animal models [34, 35] and human studies [36, 37].”
Aljumayi, H., Alrasheedi, A. A., Aljutaily, T., Ahmed, I. A. M., & Khalil, N. A. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4503 · Cited by 7
Hosseini, F., Pourjam, M., Mirzaeian, S., Karimifar, M., Feizi, A., Entezari, M. H., & Saraf‐Bank, S. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4124 · Cited by 8
“…trials assessing the effects of probiotic products, including yogurt (Rezazadeh et al., 2019 ), fermented milk (Bernini et al., 2016 ), and Kefir (Bellikci-Koyu et al., 2019 ), as well as probiotic and synbiotic supplements (Eslamparast et al., 2014 ; Tenorio-Jiménez et al., 2019 ) on MetS have…”
BackgroundFermented Beverages Revisited: From Terroir to Customized Functional Products
Paramithiotis, S., Patra, J. K., Kotseridis, Y., & Dimopoulou, M. (2024) · Fermentation · doi:10.3390/fermentation10010057 · Cited by 11
Zahidah, I., & Bölek, S. (2023) · Current Nutrition & Food Science · doi:10.2174/1573401319666230809141544 · Cited by 8
Yahyapoor, F., Haghighat, N., Sohrabi, Z., Asbaghi, O., Bagherniya, M., Jamialahmadi, T., & Sahebkar, A. (2023) · Current Drug Targets · doi:10.2174/1389450124666230427095742 · Cited by 12
Food Products with High Antioxidant and Antimicrobial Activities and Their Sensory Appreciation
Tița, M. A., Constantinescu, M. A., Tiţa, O., et al. (2022) · Applied Sciences · doi:10.3390/app12020790 · Cited by 7
Mendes, E., Casaro, M. B., Fukumori, C., Ribeiro, W. R., dos Santos, A. L., Sartorelli, P., Lazarini, M., Bogsan, C. S. B., Oliveira, M. A., & Ferreira, C. M. (2021) · Beneficial Microbes · doi:10.3920/bm2020.0112 · Cited by 7
Kefir Consumption and Health Effects Based on Human Clinical Trials: An Overview of Literature
Fijan, S., Povalej, P., Pogačar, M. Š., & Klanjšek, P. (2026) · Healthcare · doi:10.3390/healthcare14050652 · Cited by 12
“…with improved metabolic and cardiovascular parameters, including HDL-C, LDL-C, ApoA1, triglycerides, glycemic index, blood pressure, fat-free mass, and reduced cardiovascular risk, with effects often dependent on microbial composition and specific strains [35,40,42–44 ,46 ,49, 51, 52, 62].”
InfluentialImpact of Fermented Dairy on Gastrointestinal Health and Associated Biomarkers
Bui, G., & Marco, M. L. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf114 · Cited by 17
Aryal, S., Manandhar, I., Mei, X., Yeoh, B. S., Tummala, R., Saha, P., Osman, I., Zubcevic, J. A., Durgan, D. J., Vijay–Kumar, M., et al. (2023) · Cambridge Prisms Precision Medicine · doi:10.1017/pcm.2023.13 · Cited by 9
Chai, W., Maskarinec, G., Lim, U., Boushey, C. J., Wilkens, L. R., Setiawan, V. W., Marchand, L. L., Randolph, T. W., Jenkins, I., Lampe, J. W., et al. (2023) · Gut Microbiome · doi:10.1017/gmb.2023.10 · Cited by 7
“Another study observed a positive correlation between abundance of Odoribacter and fasting plasma glucose (Bellikci-Koyu et al., 2019).”
Role of gut microbiota in metabolic syndrome: a review of recent evidence
Alveirinho, M., Freitas, P., & Faleiro, M. L. (2020) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000105 · Cited by 6
“Despite not reaching statistical significance, several of the changes were correlated with improvements in anthropometric measurements.(14) Yoghurt consumption also appears to have an effect on gut microbiota, biochemical parameter and body composition.”
ResultRashidbeygi, E., Samarin, M. M., Sheikhhossein, F., Khalilkhaneh, A. H., Gholizadeh, M., Lohrasbi, N., Abbasi, A., Bazyar, H., Askari, G., & Amini, M. R. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70124 · Cited by 8
Lawrence, K., Fibert, P., Hobbs, J., Myrissa, K., Toribio-Mateas, M. A., Quadt, F., Cotter, P. D., & Gregory, A. M. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071063 · Cited by 10
“31 32 Preliminary evidence, from small-scale animal models, suggests that supplementation with kefir may be linked to behavioural effects such as less fatigue 33 and changes in reward-seeking and repetitive behaviour.”
The Role of Fermented Dairy Products in Human Health
Garory, N. H. S. A., ABDUL-ABBAS, S. J., & Al-Hashimi, A. G. (2023) · Bionatura · doi:10.21931/rb/css/2023.08.02.66 · Cited by 5
“It leads to a reduction in cholesterol and low-density lipoproteins (LDL) and an increase in the concentration of high-density lipoproteins (HDL), thus reducing the risk of coronary heart disease 6 .”
BackgroundBellikci-Koyu, E., Sarer-Yurekli, B. P., Akyön, Y., et al. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121000707 · Cited by 5
Self-citationRyan, S. M., & Brayden, D. J. (2026) · Frontiers in Drug Delivery · doi:10.3389/fddev.2026.1692219 · Cited by 14
Hamsho, M., Hawari, R., Yeşil, Z., Dakhel, Z., Saydam, D. D., Terzi, M., & Ranneh, Y. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104364 · Cited by 11
Malta, S. M., Rodrigues, T. S., Silva, M. H., Marquez, A. S., Ferreira, R. B., Mascarenhas, F. N. A. D. P., Zanon, R. G., Bernardes, L. M. M., Batista, L. L., da Silva, M. N. T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76601-9 · Cited by 8
“Kefir’s use ranges from treating and recovering from dysbiosis on its own 37 to serving as an adjuvant in the treatment of related diseases, including inflammatory 38 , neurodegenerative 39 and metabolic syndrome 40 .”
Metadata
- Authors
- BELLIKCI-KOYU, E., SARER-YUREKLI, B. P., AKYON, Y., AYDIN-KOSE, F., KARAGOZLU, C., OZGEN, A. G., BRINKMANN, A., NITSCHE, A., ERGUNAY, K., YILMAZ, E., & BUYUKTUNCER, Z.
- Affiliations
- Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara 06230, Turkey
- Ege University (TR)
- Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey
- Department of Biochemistry, Faculty of Pharmacy, Ege University, Izmir 35040, Turkey
- Department of Dairy Technology, Faculty of Agriculture, Ege University, Izmir 35040, Turkey
- Department of Endocrinology, Faculty of Medicine, Ege University, Izmir 35040, Turkey
- Robert Koch Institute (DE)
- Department of Medical Biology, Acıbadem Mehmet Ali Aydınlar University, Istanbul 34752, Turkey
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-09-04
- Volume
- 11
- Issue
- 9
- Pages
- 2089
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6769690
- OpenAlex
- W2971933675
- Cited by
- 144
- References
- 86
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 24 · 2023: 25 · 2022: 21 · 2021: 22 · 2020: 14 · 2019: 1
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Acibadem University Open Access Repository (submittedVersion)
- Publication server of the Robert Koch Institute (Robert Kock Institute) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, cc-by)
- Funders
- Turkish Council of Higher Education (XX)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Keywords
- kefir, gut microbiota, metabolic syndrome, fermented milk, insulin resistance, fasting insulin, HOMA-IR, blood pressure, TNF-α, interferon-gamma, actinobacteria, Bacteroidetes, Proteobacteria, Verrucomicrobia, probiotics
- MeSH terms
- Gastrointestinal Microbiome, Kefir, Adolescent, Adult, Aged, Blood Glucose, Body Weight, Female, Humans, Lipids, Male, Middle Aged, Phylogeny, Metabolic Syndrome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.